|
1
|
McMurray JJ and Pfeffer MA: Heart failure.
Lancet. 365:1877–1889. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roger VL, Weston SA, Redfield MM, et al:
Trends in heart failure incidence and survival in a community-based
population. JAMA. 292:344–350. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tessier-Lavigne M and Goodman CS: The
molecular biology of axon guidance. Science. 274:1123–1133. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Barallobre MJ, Pascual M, Del RJ and
Soriano E: The Netrin family of guidance factors: emphasis on
Netrin-1 signalling. Brain Res Brain Res Rev. 49:22–47. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tadagavadi RK, Wang W and Ramesh G:
Netrin-1 regulates Th1/Th2/Th17 cytokine production and
inflammation through UNC5B receptor and protects kidney against
ischemia-reperfusion injury. J Immunol. 185:3750–3758. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rosenberger P, Schwab JM, Mirakaj V, et
al: Hypoxia-inducible factor-dependent induction of netrin-1
dampens inflammation caused by hypoxia. Nat Immunol. 10:195–202.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang W, Reeves WB, Pays L, Mehlen P and
Ramesh G: Netrin-1 overexpression protects kidney from ischemia
reperfusion injury by suppressing apoptosis. Am J Pathol.
175:1010–1018. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ly NP, Komatsuzaki K, Fraser IP, et al:
Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proc
Natl Acad Sci USA. 102:14729–14734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mirakaj V, Thix CA, Laucher S, et al:
Netrin-1 dampens pulmonary inflammation during acute lung injury.
Am J Respir Crit Care Med. 181:815–824. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mirakaj V, Gatidou D, Potzsch C, Konig K
and Rosenberger P: Netrin-1 signaling dampens inflammatory
peritonitis. J Immunol. 186:549–555. 2011. View Article : Google Scholar
|
|
11
|
Rosenberger P, Schwab JM, Mirakaj V, et
al: Hypoxia-inducible factor-dependent induction of netrin-1
dampens inflammation caused by hypoxia. Nat Immunol. 10:195–202.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Grenz A, Dalton JH, Bauerle JD, et al:
Partial netrin-1 deficiency aggravates acute kidney injury. PLoS
One. 6:e148122011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aherne CM, Collins CB, Masterson JC, et
al: Neuronal guidance molecule netrin-1 attenuates inflammatory
cell trafficking during acute experimental colitis. Gut.
61:695–705. 2012. View Article : Google Scholar :
|
|
14
|
Zhang J and Cai H: Netrin-1 prevents
ischemia/reperfusion-induced myocardial infarction via a
DCC/ERK1/2/eNOS s1177/NO/DCC feed-forward mechanism. J Mol Cell
Cardiol. 48:1060–1070. 2010. View Article : Google Scholar :
|
|
15
|
Durrani S, Haider KH, Ahmed RP, Jiang S
and Ashraf M: Cytoprotective and proangiogenic activity of ex-vivo
netrin-1 transgene overexpression protects the heart against
ischemia/reperfusion injury. Stem Cells Dev. 21:1769–1778. 2012.
View Article : Google Scholar :
|
|
16
|
Ahmed RP, Haider KH, Shujia J, Afzal MR
and Ashraf M: Sonic Hedgehog gene delivery to the rodent heart
promotes angiogenesis via iNOS/netrin-1/PKC pathway. PLoS One.
5:e85762010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Joseph BB and Quan PD: The neuroimmune
guidance cue netrin-1: a new therapeutic target in cardiovascular
disease. Am J Cardiovasc Dis. 3:129–134. 2013.PubMed/NCBI
|
|
18
|
Shishido T, Woo CH, Ding B, et al: Effects
of MEK5/ERK5 association on small ubiquitin-related modification of
ERK5: implications for diabetic ventricular dysfunction after
myocardial infarction. Circ Res. 102:1416–1425. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Funayama A, Shishido T, Netsu S, et al:
Cardiac nuclear high mobility group box 1 prevents the development
of cardiac hypertrophy and heart failure. Cardiovasc Res.
99:657–664. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Le NT, Takei Y, Shishido T, et al: p90RSK
targets the ERK5-CHIP ubiquitin E3 ligase activity in diabetic
hearts and promotes cardiac apoptosis and dysfunction. Circ Res.
110:536–550. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jones ME, Mayne GC, Wang T, Watson DI and
Hussey DJ: A fixed-point algorithm for estimating amplification
efficiency from a polymerase chain reaction dilution series. BMC
Bioinformatics. 15:3722014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li H, Tang QZ, Liu C, et al: Cellular
FLICE-inhibitory protein protects against cardiac remodeling
induced by angiotensin II in mice. Hypertension. 56:1109–1117.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ly NP, Komatsuzaki K, Fraser IP, et al:
Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proc
Natl Acad Sci USA. 102:14729–14734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Siggens L, Figg N, Bennett M and Foo R:
Nutrient deprivation regulates DNA damage repair in cardiomyocytes
via loss of the base-excision repair enzyme OGG1. FASEB J.
26:2117–2124. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Suzuki S, Shishido T, Ishino M, et al:
8-Hydroxy-2′-deoxyguanosine is a prognostic mediator for cardiac
event. Eur J Clin Invest. 41:759–766. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang H, Ozaki T, Shamim HM, et al: A newly
identified dependence receptor UNC5H4 is induced during DNA
damage-mediated apoptosis and transcriptional target of tumor
suppressor p53. Biochem Biophys Res Commun. 370:594–598. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Van Berlo JH, Maillet M and Molkentin JD:
Signaling effectors underlying pathologic growth and remodeling of
the heart. J Clin Invest. 123:37–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Garrington TP and Johnson GL: Organization
and regulation of mitogen-activated protein kinase signaling
pathways. Curr Opin Cell Biol. 11:211–218. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kuida K and Boucher DM: Functions of MAP
kinases: insights from gene-targeting studies. J Biochem.
135:653–656. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ravingerova T, Barancik M and Strniskova
M: Mitogen-activated protein kinases: a new therapeutic target in
cardiac pathology. Mol Cell Biochem. 247:127–138. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang Y: Mitogen-activated protein kinases
in heart development and diseases. Circulation. 116:1413–1423.
2007. View Article : Google Scholar : PubMed/NCBI
|
